Royal Bank Of Canada Agile Therapeutics Inc Transaction History

Royal Bank Of Canada

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.21 - $0.31 $1 - $1	6 Added 16.67%	42 $0
Q4 2022 Feb 14, 2023	BUY	$0.18 - $15.25 $4 - $411	27 Added 300.0%	36 $0
Q3 2022 Nov 14, 2022	BUY	$0.28 - $14.85 $0 - $29	2 Added 28.57%	9 $0
Q2 2022 Aug 15, 2022	BUY	$1.09 - $8.24 $7 - $57	7 New	7 $0

Ticker AGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 39,023,000
Description
Agile Therapeutics, Inc., a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States. Its lead product is Twirla, also known as AG200-15, a once-weekly prescription combination hormonal contraceptive patch. The company is also developing a pipeline of Twirla line exte...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.